PETER HUDSPETH is a highly experienced
                              healthcare professional with a proven track
                              record of success spanning more than 30 years
                              on both client and agency sides of the business.

                                     He has gained a reputation for being
                               strategically focused, having excellent
                               organisational and planning skills, and
                              delivering the highest levels of service to clients.

      Peter has launched and/or managed many major human and animal healthcare brands, including: Aggrastat, Aricept, Canesten, Capoten, Clexane/Lovenox, Cozaar, Dectomax, Eprinex, Eqvalan, Ivomec, Keppra, Mepact, Nicorette, Omacor, Optimmune, Oramec, Pariet, Reyataz, SMA, Symbicort, Toviaz and Xyzal.

      He has previously held agency management positions at Dratfcb Healthcare (Interpublic Group), LEC\TBWA\WorldHealth (Omnicom Group) and Euro RSCG Healthcare (Havas).

JEFF DANIELS began his career in FMCG

brand development before specialising in OTC

and Rx healthcare.

      He has contributed to the success of many

of the world's leading brands in addition to a

number of specialty/niche brands and has

been awarded more than 40 international

creative awards and commendations.

       Jeff's experience covers almost all therapeutic categories,

and major brands he has helped launch, or relaunch, include: Atripla, Crestor, Imigran, Innovace, KeppraMepact,

MirenaNeoClarityn, Plavix, ReyatazSingulair, Spiriva, Sustiva, Toviaz, TritaceVesicare, Viagra, Xyzal, and Zantac.

     He has previously held creative director positions at Draftfcb Healthcare (Interpublic Group), LEC\TBWA\WorldHealth (Omnicom Group) and Grey Healthcare Group (WPP).

Mobile: +44 (0)7831 337 005

Office:  +44 (0)20 7887 6046


Mobile: +44 (0)7748 184 119

Office:  +44 (0)20 7887 6046

© Copyright 2016 Daniels Hudspeth Ltd. All Rights Reserved.